Researchers uncover new pathways for diabetes research

A new Florida State University study is changing how scientists look at diabetes research and the drugs used to treat the disease. In a recent issue of Proceedings of the National Academy of Sciences, Associate Professor of Chemistry Brian Miller and post-doctoral researcher Carl Whittington report that a key enzyme involved in the body’s response to glucose can essentially be corrupted by a new mechanism that scientists have not seen before. This discovery shifts the current understanding of how this enzyme participates in certain diseases, including hyperinsulinemia and diabetes.